Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes (2023 - 2025)

Historic Current Taxes for China Pharma Holdings (CPHI) over the last 7 years, with Q3 2025 value amounting to $691677.0.

  • China Pharma Holdings' Current Taxes rose 7326.06% to $691677.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $691677.0, marking a year-over-year increase of 7326.06%. This contributed to the annual value of $595476.0 for FY2024, which is 4202.84% down from last year.
  • China Pharma Holdings' Current Taxes amounted to $691677.0 in Q3 2025, which was up 7326.06% from $741376.0 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Current Taxes registered a high of $1.0 million during Q4 2023, and its lowest value of $399212.0 during Q3 2024.
  • Moreover, its 3-year median value for Current Taxes was $643576.5 (2024), whereas its average is $668344.8.
  • Its Current Taxes has fluctuated over the past 5 years, first crashed by 4202.84% in 2024, then skyrocketed by 7326.06% in 2025.
  • Over the past 3 years, China Pharma Holdings' Current Taxes (Quarter) stood at $1.0 million in 2023, then tumbled by 42.03% to $595476.0 in 2024, then increased by 16.16% to $691677.0 in 2025.
  • Its Current Taxes stands at $691677.0 for Q3 2025, versus $741376.0 for Q2 2025 and $555142.0 for Q1 2025.